Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage

OBJECTIVES: The benefit of adjuvant chemotherapy in patients with localized uterine leiomyosarcoma (LMS) remains unclear due to a lack of randomized studies and data only from small retrospective series to rely on. We sought to identify factors associated with the administration of chemotherapy and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sarcoma
Egile Nagusiak: Patel, Dhara, Handorf, Elizabeth, von Mehren, Margaret, Martin, Lainie, Movva, Sujana
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6387708/
https://ncbi.nlm.nih.gov/pubmed/30881199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3561501
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak